Clinical Trials Browser

Sezary Syndrome × Gemcitabine × 90 days × Clear all

NCT04960618 2026-03-23

Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

Phase 2 Active not recruiting

Mycosis Fungoides, Sezary Syndrome